Donor-derived stem cells for orthopedic physicians
Raised to date
$300K
of $2M offered across 1 Form D filing
TAVRA Biosciences supplies off-the-shelf bone marrow-derived mesenchymal stem cells to licensed physicians for orthopedic, sports medicine and pain practices. The cells come from donors aged 18 to 25 and are made in an FDA-registered, cGMP-compliant cleanroom. Each lot has a third-party certificate of analysis covering viability, potency, purity and sterility. The products are not FDA-approved.
Sells cGMP-manufactured donor cells with lot-level third-party testing for localized physician use.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Apr 15, 2026 | Equity | $300K/ $2M | Form D |
Cell-based biologics
Off-the-shelf mesenchymal stem cells from young adult donors, supplied to licensed physicians.
Built for
Licensed physicians in orthopedic, sports medicine and pain-focused practices